AERIE PHARMACEUTICALS INC Insider Trading for June 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AERIE PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in AERIE PHARMACEUTICALS INC for June 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 13 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Option Exercise | M | 3.15 | 50,000 | 157,500 | 846,329 | |
| Jun 13 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Sell | S | 62.92 | 4,996 | 314,350 | 126,320 | 131.3 K to 126.3 K (-3.80 %) |
| Jun 13 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Sell | S | 61.90 | 45,004 | 2,785,946 | 131,316 | 176.3 K to 131.3 K (-25.52 %) |
| Jun 13 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Buy | M | 3.15 | 50,000 | 157,500 | 176,320 | 126.3 K to 176.3 K (+39.58 %) |
| Jun 08 2018 | AERI | AERIE PHARMACEUTIC ... | McHugh Julie | Director | Option Exercise | A | 65.15 | 7,800 | 508,170 | 7,800 | |
| Jun 08 2018 | AERI | AERIE PHARMACEUTIC ... | McHugh Julie | Director | Grant | A | 0.00 | 1,750 | 0 | 4,600 | 2.9 K to 4.6 K (+61.40 %) |
| Jun 08 2018 | AERI | AERIE PHARMACEUTIC ... | Kopczynski Casey C. | Chief Scientific Of ... | Sell | S | 59.21 | 3,000 | 177,641 | 180,517 | 183.5 K to 180.5 K (-1.63 %) |
| Jun 08 2018 | AERI | AERIE PHARMACEUTIC ... | Kopczynski Casey C. | Chief Scientific Of ... | Sell | S | 58.57 | 8,000 | 468,595 | 183,517 | 191.5 K to 183.5 K (-4.18 %) |
| Jun 08 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Option Exercise | M | 3.15 | 26,139 | 82,338 | 896,329 | |
| Jun 08 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Option Exercise | M | 2.90 | 23,861 | 69,197 | 0 | |
| Jun 08 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Option Exercise | M | 2.90 | 50,000 | 145,000 | 23,861 | |
| Jun 08 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Option Exercise | M | 2.90 | 50,000 | 145,000 | 73,861 | |
| Jun 08 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Sell | S | 64.52 | 29,717 | 1,917,362 | 126,320 | 156 K to 126.3 K (-19.04 %) |
| Jun 08 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Sell | S | 63.35 | 20,283 | 1,284,924 | 156,037 | 176.3 K to 156 K (-11.50 %) |
| Jun 08 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Buy | M | 3.15 | 26,139 | 82,338 | 176,320 | 150.2 K to 176.3 K (+17.40 %) |
| Jun 08 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Buy | M | 2.90 | 23,861 | 69,197 | 150,181 | 126.3 K to 150.2 K (+18.89 %) |
| Jun 08 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Sell | S | 62.80 | 16,386 | 1,029,092 | 126,320 | 142.7 K to 126.3 K (-11.48 %) |
| Jun 08 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Sell | S | 62.06 | 33,614 | 2,085,957 | 142,706 | 176.3 K to 142.7 K (-19.06 %) |
| Jun 08 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Buy | M | 2.90 | 50,000 | 145,000 | 176,320 | 126.3 K to 176.3 K (+39.58 %) |
| Jun 08 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Sell | S | 61.10 | 4,338 | 265,044 | 126,320 | 130.7 K to 126.3 K (-3.32 %) |
| Jun 08 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Sell | S | 60.44 | 45,662 | 2,760,003 | 130,658 | 176.3 K to 130.7 K (-25.90 %) |
| Jun 08 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Buy | M | 2.90 | 50,000 | 145,000 | 176,320 | 126.3 K to 176.3 K (+39.58 %) |
| Jun 08 2018 | AERI | AERIE PHARMACEUTIC ... | MCGRAW BENJAMIN F III | Director | Option Exercise | A | 65.15 | 7,800 | 508,170 | 7,800 | |
| Jun 08 2018 | AERI | AERIE PHARMACEUTIC ... | MCGRAW BENJAMIN F III | Director | Grant | A | 0.00 | 1,750 | 0 | 6,300 | 4.6 K to 6.3 K (+38.46 %) |
| Jun 08 2018 | AERI | AERIE PHARMACEUTIC ... | GOLDBERG MURRAY A | Director | Option Exercise | A | 65.15 | 7,800 | 508,170 | 7,800 | |
| Jun 08 2018 | AERI | AERIE PHARMACEUTIC ... | GOLDBERG MURRAY A | Director | Grant | A | 0.00 | 1,750 | 0 | 6,300 | 4.6 K to 6.3 K (+38.46 %) |
| Jun 08 2018 | AERI | AERIE PHARMACEUTIC ... | du Toit Michael | Director | Option Exercise | A | 65.15 | 7,800 | 508,170 | 7,800 | |
| Jun 08 2018 | AERI | AERIE PHARMACEUTIC ... | du Toit Michael | Director | Grant | A | 0.00 | 1,750 | 0 | 4,600 | 2.9 K to 4.6 K (+61.40 %) |
| Jun 08 2018 | AERI | AERIE PHARMACEUTIC ... | Croarkin Richard | Director | Option Exercise | A | 65.15 | 7,800 | 508,170 | 7,800 | |
| Jun 08 2018 | AERI | AERIE PHARMACEUTIC ... | Croarkin Richard | Director | Grant | A | 0.00 | 1,750 | 0 | 4,600 | 2.9 K to 4.6 K (+61.40 %) |
| Jun 08 2018 | AERI | AERIE PHARMACEUTIC ... | Cagle Gerald D. | Director | Option Exercise | A | 65.15 | 7,800 | 508,170 | 7,800 | |
| Jun 08 2018 | AERI | AERIE PHARMACEUTIC ... | Cagle Gerald D. | Director | Grant | A | 0.00 | 1,750 | 0 | 17,800 | 16.1 K to 17.8 K (+10.90 %) |